[Tourette's syndrome and antidepressant therapy: exacerbation of nervous tics with paroxetine].

One possible side effect of selective serotonin re-uptake inhibitors (SSRI) is the exacerbation of nervous tics in a 12-year-old boy treated with tiapride following prescription of paroxetine for a depressive syndrome. Potential causal factors include residual cholinergic activity of paroxetine, the observably increased drive under paroxetine, metabolic properties, and protein binding. The problem of side effects under selective serotonin re-uptake inhibitors, as well as the issues of co-morbidity and co-medication in the treatment of nervous tics and Tourette's Syndrome are discussed.

[1]  K. B. Jones-Fearing SSRI AND ESP WITH FLUOXETINE , 1996 .

[2]  G. Sachs,et al.  Akathisia: a review and case report following paroxetine treatment. , 1996, Comprehensive psychiatry.

[3]  R. Hauser,et al.  Sertraline‐induced exacerbation of Tics in Tourette's syndrome , 1995, Movement disorders : official journal of the Movement Disorder Society.

[4]  R. Bruun,et al.  Combined pharmacotherapy risk. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

[5]  L. J. Barnhill,et al.  Paroxetine-pimozide drug interaction. , 1994, Journal of the American Academy of Child and Adolescent Psychiatry.

[6]  D. Jermain,et al.  Fluoxetine and Tics in an Adolescent , 1993, The Annals of pharmacotherapy.

[7]  M. Mcdermott,et al.  A pilot controlled study of fluoxetine for obsessive-compulsive symptoms in children with Tourette's syndrome. , 1993, Clinical neuropharmacology.

[8]  N. Müller Exacerbation of tics following antidepressant therapy in a case of Gilles-de-la-Tourette syndrome. , 1992, Pharmacopsychiatry.

[9]  H. Hermesh,et al.  Clomipramine efficacy for tics, obsessions, and compulsions in tourette's syndrome and obsessive-compulsive disorder: A case study , 1990, Biological Psychiatry.

[10]  C. Ludlow,et al.  Cholinergic treatment in the Tourette syndrome. , 1980, The New England journal of medicine.